Latest Articles
NICE approves first immunotherapy combination for endometrial cancer - NICE website
NICE approves first immunotherapy combination for endometrial cancer NICE website
Published: Aug. 5, 2025, 11 p.m.
B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight - The Malaysian Reserve
B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight The Malaysian Reserve
Published: July 24, 2025, 10:55 p.m.
Advanced Ovarian and Endometrial Cancers Respond to Combination Immunotherapy - Labroots
Advanced Ovarian and Endometrial Cancers Respond to Combination Immunotherapy Labroots
Published: July 14, 2025, 10 a.m.
Dual Immunotherapy Shows Activity in Clear Cell Gynecologic Cancers - MedPage Today
Dual Immunotherapy Shows Activity in Clear Cell Gynecologic Cancers MedPage Today
Published: July 3, 2025, 3 p.m.
Endometrial Cancer - Pipeline Insight, 2025: Immunotherapy - openPR.com
Endometrial Cancer - Pipeline Insight, 2025: Immunotherapy openPR.com
Published: June 30, 2025, 6:49 p.m.
Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer - Medical Xpress
Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer Medical Xpress
Published: June 2, 2025, 6:20 p.m.
Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer | Newswise - Newswise
Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer | Newswise Newswise
Published: June 2, 2025, 2:25 p.m.
‘No surgery, no chemo’: new cancer trial shows 100% remission with immunotherapy - Mathrubhumi English
‘No surgery, no chemo’: new cancer trial shows 100% remission with immunotherapy Mathrubhumi English
Published: May 6, 2025, 10:03 a.m.
Second Immunotherapy Exposure: Understanding Efficacy and Safety in Endometrial and Cervical Carcinoma - OncLive
Second Immunotherapy Exposure: Understanding Efficacy and Safety in Endometrial and Cervical Carcinoma OncLive
Published: April 28, 2025, 1:18 p.m.
Rethinking Immunotherapy: A Case for Personalization in Advanced Endometrial Cancer - HMP Global Learning Network
Rethinking Immunotherapy: A Case for Personalization in Advanced Endometrial Cancer HMP Global Learning Network
Published: April 11, 2025, 2:54 p.m.
Link copied to clipboard!